Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells

Journal of General Virology

Volumn 78, Issue 7, 1997, Pages 1663-1670

  Gutierrez M I ^a   Raj, A ^a   Spangler, G ^a   Sharma, A ^a   Hussain, A ^a   Judde, J G ^a   Tsao, S W ^b   Yuen, P W ^b   Joab, I ^c   Magrath, I T ^a   Bhatia, K ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS ANTIGEN;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NASOPHARYNX CARCINOMA; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR CELL; VIRION; VIRUS CARCINOGENESIS; VIRUS ONCOGENE; VIRUS TRANSMISSION;

HUMAN HERPESVIRUS 4;

EID: 1842289849     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-7-1663     Document Type: Article

References (23)

1. Adldinger, H. K., Delius, H., Freese, U. K., Clarke, J. & Bornkamm, G. W. (1985). A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141, 121-134.
2. Allday, M. J. & Crawford, D. H. (1988). Role of epithelium in EBV persistence and pathogenesis of B-cell tumors. Lancet i, 855-857.
3. Anagnostopoulos, I., Hummel, M., Kreschel, C. & Stein, H. (1995). Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85, 744-750.
4. Bhatia, K., Raj, A., Gutiérrez, M. I., Judde, J.-G., Spangler, G., Venkatesh, H. & Magrath, I. T. (1996). Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13, 177-181.
5. Boyle, M. J., Sewell, W. A., Sculley, T. B., Apolloni, A., Turner, J. J., Swanson, C. E., Penny, R. & Cooper, D. A. (1991). Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 78, 3004-3011.
6. Duarte, E. A., Novella, I. S., Weaver, S. C., Domingo, E., Wain-Hobson, S., Clarke, D. K., Moya, A., Elena, S. F., de la Torre, J. C. & Holland, J. J. (1994). RNA virus quasispecies: significance for viral disease and epidemiology. Infectious Agents and Disease 3, 201-214.
7. Eigen, M. (1993). The origin of genetic information; viruses as models. Gene 135, 37-47.
8. Goldschmidts, W. L., Bhatia, K., Johnson, J. F., Akar, N., Gutiérrez, M. I., Shibata, D., Carolan, M., Levine, A. & Magrath, I. (1992). Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 6, 875-878.
9. Klein, G. (1994). The paradoxical coexistence of EBV and the human species. Epstein-Barr Virus Report 1, 5-9.
10. Knox, P. G., Li, Q. X., Rickinson, A. B. & Young, L. S. (1996). In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus: cell interaction observed in nasopharyngeal carcinoma. Virology 215, 40-50.
11. Magrath, I., Jain, V. & Bhatia, K. (1993). Molecular epidemiology of Burkitt's lymphoma. Epstein-Barr Virus Associated Diseases 225, 377-396.
12. Miller, G. (1990). Epstein-Barr virus: biology, pathogenesis and medical aspects. In Fields Virology, 2nd edn, pp. 1921-1958. Edited by B. N. Fields & D. M. Knipe. New York: Raven Press.
13. Molla, A., Korneyeva, M., Gao, Q., Vasasanonda, S., Schipper, P., Mo, H. M., Markowitz, M., Chernyavskiy, T., Niu, P., Lyons, N. & Hssu, A. (1996). Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine 2, 760-766.
14. Rowe, M., Young, L. S., Cadwallader, K., Petti, L., Kieff, E. & Rickinson, A. B. (1989). Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. Journal of Virology 63, 1031-1039.
15. Sample, J., Young, L. S., Martin, B., Chatman, T., Kieff, E. & Rickinson, A. B. (1990). Epstein-Barr virus types 1 and 2 differ in their EBNA 3A, 3B and 3C genes. Journal of Virology 64, 4084-4092.
16. Sculley, T. B., Apolloni, A., Stumm, R., Moss, D. J., Mueller-Lantczh, N., Misko, I. S. & Cooper, D. A. (1989). Expression of Epstein-Barr virus nuclear antigens 3, 4 and 6 are altered in cell lines containing B type virus. Virology 171, 401-408.
17. Sixbey, J. W., Shirley, P., Chesney, P. J., Buntin, D. M. & Resnick, L. (1989). Detection of a second widespread strain of Epstein-Barr virus. Lancet 2, 761-765.
18. Snudden, D. K., Smith, P. R., Lai, D., Ng, M.-H. & Griffin, B. E. (1995). Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumors. Oncogene 10, 1545-1552.
19. Tao, Q., Srivastava, G., Chan, A. C., Chung, L. P., Loke, S. L. & Ho, F. C. (1995). Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. Journal of Medical Virology 45, 71-77.
20. Wilson, J. B., Bell, J. L. & Levine, A. J. (1996). Expression of Epstein-Barr virus nuclear antigen-1 induces B ceil neoplasia in transgenic mice. EMBO Journal 15, 3117-3126.
21. Wrightham, M. N., Stewart, J. P., Janjua, N. J., Pepper, S. D., Sample, C., Rooney, C. M. & Arrand, J. R. (1995). Antigenic and sequence variation in the C terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208, 521-530.
22. Yao, Q. Y., Rickinson, A. B. & Epstein, M. A. (1985). A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35, 35-42.
23. zur Hausen, H., Schulte-Holthausen, H., Klein, G., Henle, W., Henle, G., Clifford, P. & Santesson, L. (1970). EBV DNA in biopsies of Burkitt's tumors and anaplastic carcinomas of the nasopharynx. Nature 228, 1056-1058.